Seminars in Pediatric Neurology
Volume 12, Issue 2 , Pages 88-96 , June 2005

Antiepileptic Drug Monotherapy: Pediatric Concerns

  • Joseph E. Sullivan III, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Joseph E. Sullivan III, MD, Division of Neurology, The Children’s Hospital of Philadelphia, University of Pennsylvania School of Medicine, 34th Street and Civic Center Blvd, Philadelphia, PA.
    • ,
  • Dennis J. Dlugos, MD, MSCE

References 

  1. Camfield PR , Camfield CS , Gordon K , et al.   If a first antiepileptic drug fails to control a child’s epilepsy, what are the chances of success with the next drug? . J Pediatr . 1997;131:821–824
  2. Berg AT , Shinnar S , Levy SR , et al.   How well can epilepsy syndromes be identified at diagnosis? A reassessment 2 years after initial diagnosis . Epilepsia . 2000;41:1269–1275
  3. Idiopathic Generalized Epilepsies . In:  Panayiotopoulos CP editors. A Clinical Guide to Epileptic Syndromes and their Treatment . Chipping Norton, Oxfordshire: Blandon Medical Publishing; 2002;p. 114
  4. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy . Epilepsia . 1989;30:389–399
  5. Mattson RH , Cramer JA , Collins JF , et al.   Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures . N Engl J Med . 1985;313:145–151
  6. Verity CM , Hosking G , Easter DJ  The Paediatric EPITEG Collaborative Group . A multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy . Dev Med Child Neurol . 1995;37:97–108
  7. de Silva M , MacArdle B , McGowan M , et al.   Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy . Lancet . 1996;347:709–713
  8. Sullivan JE , Dlugos DJ . Idiopathic generalized epilepsy . Curr Treat Options Neurol . 2004;6:231–242
  9. Delgado-Escueta AV , Enrile-Bacsal F . Juvenile myoclonic epilepsy of Janz . Neurology . 1984;34:285–294
  10. Penry JK , Dean JC , Riela AR . Juvenile myoclonic epilepsy (long-term response to therapy) . Epilepsia . 1989;304(suppl 4):S19–S23
  11. Prasad A , Kuzniecky RI , Knowlton RC , et al.   Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy . Arch Neurol . 2003;60:1100–1105
  12. Faught E . Clinical trials for treatment of primary generalized epilepsies . Epilepsia . 2003;44(suppl 7):44–50
  13. Gericke CA , Picard F , de Saint-Martin A , et al.   Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes (a video-EEG-controlled, open study) . Epileptic Disord . 1999;1:159–165
  14. Bourgeois B , Beaumanoir A , Blajev B , et al.   Monotherapy with valproate in primary generalized epilepsies . Epilepsia . 1987;28(suppl 2):S8–S11
  15. Nieto-Barrera M , Brozmanova M , Capovilla G , et al.   A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy . Epilepsy Res . 2001;46:145–155
  16. Brodie MJ , Richens A , Yuen AW  UK Lamotrigine/Carbamazepine Monotherapy Trial Group . Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy . Lancet . 1995;345:476–479
  17. Privitera MD , Brodie MJ , Mattson RH , et al.   Topiramate, carbamazepine and valproate monotherapy (double-blind comparison in newly diagnosed epilepsy) . Acta Neurol Scand . 2003;107:165–175
  18. Chadwick DW , Anhut H , Greiner MJ , et al.  International Gabapentin Monotherapy Study Group 945-77   A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures . Neurology . 1998;51:1282–1288
  19. Brodie MJ , Chadwick DW , Anhut H , et al.   Gabapentin versus lamotrigine monotherapy (a double-blind comparison in newly diagnosed epilepsy) . Epilepsia . 2002;43:993–1000
  20. Gilliam FG , Veloso F , Bomhof MA , et al.   A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy . Neurology . 2003;60:196–202
  21. Guerreiro MM , Vigonius U , Pohlmann H , et al.   A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy . Epilepsy Res . 1997;27:205–213
  22. Coppola G , Auricchio G , Federico R , et al.   Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures (an open-label, randomized, parallel-group study) . Epilepsia . 2004;45:1049–1053
  23. Bourgeois BF , Pellock JM , Schimschock JR , et al.   Gabapentin (neurontin) Monotherapy in Children with Benign Childhood Epilepsy with Centrotemporal Spikes (BECTS) (a 36-week, double-blind, placebo-controlled study) . Epilepsia . 1998;39(suppl 6):163; (abstr)
  24. Sachdeo RC , Edwards K , Hasegawa H , et al.   Safety and efficacy of oxcarbazepine 1,200 mg/day in patients with recent-onset partial epilepsy . Neurology . 1999;52(suppl 2):391; (abstr)
  25. Frank LM , Enlow T , Holmes GL , et al.   Lamictal (lamotrigine) monotherapy for typical absence seizures in children . Epilepsia . 1999;40:973–979
  26. Arroyo S , Wang S , Twyman R . Topiramate (effective as monotherapy in dose-response study in newly diagnosed epilepsy) . Epilepsia . 2002;43(suppl 7):241; (abstr)
  27. Ouellet D , Bockbrader HN , Wesche DL , et al.   Population pharmacokinetics of gabapentin in infants and children . Epilepsy Res . 2001;47:229–241
  28. Bill PA , Vigonius U , Pohlmann H , et al.   A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy . Epilepsy Res . 1997;27:195–204
  29. Dam M , Ekberg R , Loyning Y , et al.   A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy . Epilepsy Res . 1989;3:70–76
  30. Christe W , Kramer G , Vigonius U , et al.   A double-blind controlled clinical trial (oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy) . Epilepsy Res . 1997;26:451–460
  31. Chadwick D , Privitera M . Placebo-controlled studies in neurology (where do they stop?) . Neurology . 1999;52:682–685
  32. Genton P , Gelisse P , Thomas P , et al.   Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy? . Neurology . 2000;55:1106–1109
  33. Gelisse P , Genton P , Kuate C , et al.   Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies . Epilepsia . 2004;45:1282–1286
  34. Levisohn PM , Hulihan JF , Fisher AC . Topiramate versus valproate in patients with juvenile myoclonic epilepsy . Epilepsia . 2003;44(suppl 9):267; (abstr)
  35. Sander JW . The use of antiepileptic drugs—principles and practice . Epilepsia . 2004;45(suppl 6):28–34
  36. French JA , Gidal BE . Antiepileptic drug interactions . Epilepsia . 2000;41(suppl 8):S30–S36
  37. Perucca E , Dulac O , Shorvon S , et al.   Harnessing the clinical potential of antiepileptic drug therapy (dosage optimisation) . CNS Drugs . 2001;15:609–621
  38. Richens A . Rational polypharmacy . Seizure . 1995;4:211–214
  39. Kwan P , Brodie MJ . Epilepsy after the first drug fails (substitution or add-on?) . Seizure . 2000;9:464–468

PII: S1071-9091(05)00040-9

doi: 10.1016/j.spen.2005.03.003

Seminars in Pediatric Neurology
Volume 12, Issue 2 , Pages 88-96 , June 2005

Article Tools

* Image Usage & Resolution